Published in
Springer Nature [academic journals on nature.com], Blood Cancer Journal, 12(11), 2021
DOI: 10.1038/s41408-021-00590-5
Links
Tools
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial
Journal article published in 2021 by
Roberto Mina 
,
Antonietta Pia Falcone,
Sara Bringhen ,
Anna Marina Liberati ,
Norbert Pescosta,
Maria Teresa Petrucci,
Giovannino Ciccone,
Andrea Capra,
Francesca Patriarca,
Delia Rota-Scalabrini,
Francesca Bonello,
Caterina Musolino,
Michele Cea ,
Renato Zambello ,
Paola Tacchetti
and other authors.
,
Antonietta Pia Falcone,
Sara Bringhen ,
Anna Marina Liberati ,
Norbert Pescosta,
Maria Teresa Petrucci,
Giovannino Ciccone,
Andrea Capra,
Francesca Patriarca,
Delia Rota-Scalabrini,
Francesca Bonello,
Caterina Musolino,
Michele Cea ,
Renato Zambello ,
Paola Tacchetti
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Data provided by 